A "state of the science" report on diabetic hypertension concludes that controlling blood pressure may be the key factor in preventing cardiovascular disease in people who have diabetes and that angiotensin-converting enzyme (ACE) inhibitors appear to be the best means to that end.
The report, which puts the latest clinical trial results on diabetes, hypertension, and cardiovascular disease into a single update, appears in the April issue of Hypertension: Journal of the American Heart Association.
"The results of these studies point toward possible direct effects of ACE inhibitors on the heart and blood vessels in addition to their effect on blood pressure," said James Sowers, MD, of the State University of New York Health Science Center at Brooklyn. "The lessons learned from these studies suggest that ACE inhibitor therapy may improve insulin sensitivity and also delay the development of diabetes in patients at high risk." Sowers led the . . . [Full Text of this Article]
